FindTrial
Sign In

A clinical trial to study the effects of two drugs, propofol and dexmedetomidine in patients undergoing surgeries lasting less than three hours.

â??A COMPARATIVE STUDY BETWEEN INTRAVENOUS PROPOFOL INFUSION AND INTRAVENOUS DEXMEDETOMIDINE INFUSION IN PATIENTS UNDERGOING SURGERIES LASTING LESS THAN 3 HOURS UNDER CONSCIOUS SEDATIONâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026290
Enrollment
120
Registered
2020-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H60-H95- Diseases of the ear and mastoid process

Interventions

Intervention1: Dexmedetomidine: Dexmedetomidine is an α2-adrenergic agonist with beneficial sedative properties and a limited adverse effect profile. Both dexmedetomidine and clonidine are imidazole

Sponsors

Grant government medical college and sir JJ group of hospitals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age 18-60 years 2.Either sex 3.ASA grade I and II 4.Surgery lasting for

Exclusion criteria

Exclusion criteria: 1.Patientâ??s refusal 2.Pregnancy 3.Age less than 18 years and more than 60 years 4.ASA grade III and IV 5.Difficult Airway 6.Known hypersensitivity to LA drugs

Design outcomes

Primary

MeasureTime frame
Level of sedationTimepoint: Intra-op—

Secondary

MeasureTime frame
Hemodynamic stabilityTimepoint: Intra-op;Rescue analgesiaTimepoint: Post-op;Rescue analgesia requiredTimepoint: Intra-op—

Countries

India

Contacts

Public ContactDr Vaijayanti nitin gadre

Grant government medical college and sir JJ group of hospitals

pristinepavi@gmail.com9986757437

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026